A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1
about
The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysisDirect contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signalingVEGFR-2 expression in human melanoma: revised assessment.Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2Dynamic alterations in decoy VEGF receptor-1 stability regulate angiogenesis.Expression of VEGF receptors on endothelial cells in mouse skeletal muscle.Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardiumEmerging roles of post-translational modifications in signal transduction and angiogenesisVascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.Targeted therapies for advanced Ewing sarcoma family of tumors.A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial diseaseIdentification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells.Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation.Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts.Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity.Mesonephric Cell Migration into the Gonads and Vascularization Are Processes Crucial for Testis Development.Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.Expression of receptors for VEGFs on normal human thyroid follicular cells and their role in follicle formation.A novel kinase mutation in VEGFR-1 predisposes its αC-helix/activation loop towards allosteric activation: Atomic insights from protein simulation.Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity.Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models.Blood vessel anastomosis is spatially regulated by Flt1 during angiogenesis.Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle.Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.Expression of the vascular endothelial growth factor (VEGF-A) and its receptors in the umbilical cord in the course of pregnancy in the pig.The Janus Face of VEGF in Stroke.
P2860
Q26796921-8E6F745A-891C-4E0F-9F60-F30EBEC4E9C1Q27658996-DDB3EEC6-F286-4965-A16B-B8E2353DF214Q30423356-E3D5647C-D296-4E33-9FB9-5A8964803ECEQ30438929-D179262E-C80D-4341-9FD9-2C1DB2BB3B67Q33786526-B167ECA2-361F-414C-92F5-AB0CF6222F13Q34416113-94AD0590-081F-4C11-955E-C97A9287274CQ34485841-B3E200A7-7C41-4057-BF4B-7D7F77B58985Q34978408-8320F3C6-38D4-4507-A3FD-6816D74DADE6Q35049227-E7E8EA2C-E90F-4CF1-B1BC-EFDF4AAE8869Q35589492-D9BCCC4C-06DE-4323-BB85-8B6A798B046BQ35689743-E85E8AD2-B3E3-4B30-B349-5E567FD57F81Q36274594-0AFEDAD7-E063-4761-AAC7-F9C83398E2BEQ37173281-69975C79-DA8A-469B-ABEB-A4A76A6F4375Q37428138-F142D568-B279-4C7F-9883-52A21A17B14CQ37703365-B1411BDF-A852-421A-A642-6659B6167E57Q38673511-9F7F8D3B-BFE0-46D3-9DD1-9018BF8F44BEQ38853372-0B963944-3987-4094-BA8C-DE8BB39AA84BQ39059671-6692A6F2-A984-4CF6-B8A6-D80A395D5B49Q39507653-F516FAC8-6819-4387-8898-D3831BB630F2Q41691274-34D9969E-110D-40EC-BB17-4AE537F8765FQ42647940-8FA73BB2-6E37-4823-B0A9-82307D4D5C26Q43650798-D926D9D4-5F5D-4823-87F1-6C3A91570CBFQ48183560-48EE0604-DD91-4F8F-AAC1-0D9ABC7833A8Q51131994-55D5C916-ADCA-4438-84D6-70C5327249C1Q52717006-81A444DA-D73B-4B1D-BE69-E778E8B18E16Q54412258-482507BD-3B36-4159-9F71-B399D36AAB57Q55078229-0B3A2929-836A-41B4-B359-481C005CBDDF
P2860
A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@ast
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@en
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@nl
type
label
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@ast
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@en
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@nl
prefLabel
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@ast
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@en
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@nl
P2860
P356
P1476
A single amino acid substituti ...... haracteristic of VEGFR-1/FLT-1
@en
P2093
Rosana D Meyer
P2860
P304
P356
10.1074/JBC.M506454200
P407
P577
2005-11-14T00:00:00Z